4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer. [electronic resource]
- Molecular oncology Jan 2016
- 24-39 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-0261
10.1016/j.molonc.2015.07.004 doi
Antineoplastic Agents, Hormonal--therapeutic use Breast Neoplasms--drug therapy Female Humans Middle Aged Neoplasm Proteins--classification Neoplasm Recurrence, Local Tamoxifen--therapeutic use Treatment Outcome